DE69627195D1 - Purinderivate und verfahren zu ihrer herstellung - Google Patents
Purinderivate und verfahren zu ihrer herstellungInfo
- Publication number
- DE69627195D1 DE69627195D1 DE69627195T DE69627195T DE69627195D1 DE 69627195 D1 DE69627195 D1 DE 69627195D1 DE 69627195 T DE69627195 T DE 69627195T DE 69627195 T DE69627195 T DE 69627195T DE 69627195 D1 DE69627195 D1 DE 69627195D1
- Authority
- DE
- Germany
- Prior art keywords
- production
- purine derivatives
- purine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH309495 | 1995-11-01 | ||
CH221396 | 1996-09-10 | ||
PCT/EP1996/004573 WO1997016452A1 (en) | 1995-11-01 | 1996-10-22 | Purine derivatives and processes for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69627195D1 true DE69627195D1 (de) | 2003-05-08 |
DE69627195T2 DE69627195T2 (de) | 2004-01-29 |
Family
ID=25689809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69627195T Expired - Lifetime DE69627195T2 (de) | 1995-11-01 | 1996-10-22 | Purinderivate und verfahren zu ihrer herstellung |
Country Status (14)
Country | Link |
---|---|
US (1) | US7091346B1 (de) |
EP (1) | EP0874846B1 (de) |
JP (2) | JP4004066B2 (de) |
CN (1) | CN1066147C (de) |
AR (1) | AR004134A1 (de) |
AT (1) | ATE236161T1 (de) |
AU (1) | AU7296896A (de) |
BR (1) | BR9611157A (de) |
CA (1) | CA2234609C (de) |
DE (1) | DE69627195T2 (de) |
ES (1) | ES2196181T3 (de) |
HK (1) | HK1016580A1 (de) |
PT (1) | PT874846E (de) |
WO (1) | WO1997016452A1 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6794390B2 (en) * | 1996-08-02 | 2004-09-21 | Cv Therapeutics, Inc. | Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
WO1998016528A1 (en) * | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
EP1003746A1 (de) | 1997-08-07 | 2000-05-31 | The Regents Of The University Of California | Purin inhibitoren der protein kinasen, g proteine und polymerasen |
US6573044B1 (en) | 1997-08-07 | 2003-06-03 | The Regents Of The University Of California | Methods of using chemical libraries to search for new kinase inhibitors |
HUP0004512A3 (en) | 1997-10-27 | 2003-01-28 | Agouron Pharmaceuticals Inc La | 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
WO1999031072A1 (en) * | 1997-12-18 | 1999-06-24 | E.I. Du Pont De Nemours And Company | Cyclohexylamine arthropodicides and fungicides |
US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
ES2219038T3 (es) * | 1998-02-26 | 2004-11-16 | Aventis Pharmaceuticals Inc. | 2-(trans-(4-aminociclohexil)amino)purinas 6,9-disustituidas. |
US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
US6642231B2 (en) * | 1998-02-26 | 2003-11-04 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
UA66840C2 (uk) * | 1998-02-26 | 2004-06-15 | Авентіс Фармасьютікалз Інк. | 6,9-дизаміщені 2-[транс-(4-аміноциклогексил)аміно]пурини, фармацевтична композиція та способи лікування проліферативного розладу, попередження апоптозу нервових клітин, захисту нервових клітин від руйнування |
CZ27399A3 (cs) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
DE60118521T2 (de) * | 2000-01-07 | 2006-10-12 | Universitaire Instelling Antwerpen | Purin derivate, ihre herstellung und verwendung |
WO2001082967A1 (en) * | 2000-04-28 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | MEDICINAL COMPOSITIONS FOR SUPPRESSING β-AMYLOID PRODUCTION |
US6861524B2 (en) | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
ATE301123T1 (de) | 2001-06-27 | 2005-08-15 | Cyclacel Ltd | 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten |
CA2810339A1 (en) * | 2001-08-10 | 2003-02-20 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
EP1578722A4 (de) * | 2001-10-12 | 2006-09-06 | Irm Llc | Kinaseinhibitorgerüste und verfahren zu deren herstellung |
GB0219052D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New puring derivatives |
GB0219054D0 (en) | 2002-08-15 | 2002-09-25 | Cyclacel Ltd | New purine derivatives |
US7151104B2 (en) * | 2002-09-19 | 2006-12-19 | Schering Corporation | Pyrazolopyridines as cyclin dependent kinase inhibitors |
WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
CA2520465A1 (en) | 2003-03-28 | 2004-10-14 | Scios Inc. | Bi-cyclic pyrimidine inhibitors of tgf.beta. |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US7173031B2 (en) * | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
US7601713B2 (en) | 2005-12-15 | 2009-10-13 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
MY148427A (en) | 2006-12-08 | 2013-04-30 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
AU2007333394C1 (en) * | 2006-12-08 | 2011-08-18 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
MX2009010122A (es) | 2007-03-28 | 2009-10-19 | Neurosearch As | Derivados de purinilo y su uso como moduladores del canal de potasio. |
US20100105705A1 (en) * | 2007-03-28 | 2010-04-29 | Neurosearch A/S | Purinyl derivatives and their use as potassium channel modulators |
CZ302225B6 (cs) * | 2007-07-04 | 2010-12-29 | Univerzita Palackého v Olomouci | Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny |
CA2720946C (en) * | 2008-04-07 | 2013-05-28 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
EP2344501A1 (de) * | 2008-09-26 | 2011-07-20 | NeuroSearch A/S | Substituierte purinylpyrazolderivate und deren verwendung als kaliumkanalmodulatoren |
WO2010034707A1 (en) | 2008-09-26 | 2010-04-01 | Neurosearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
BR112013023050A8 (pt) | 2011-03-09 | 2018-09-25 | G Pestell Richard | antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um antagonista de ccr5, método para determinar se um indivíduo humano tendo câncer de próstata está sofrendo de ou sob o risco de desenvolver metástase, para identificar um composto candidato, para produzir in vitro células epiteliais primárias, para diagnosticar câncer de próstata, para selecionar um tratamento para um indivíduo tendo um câncer/tumor de próstata, linhagem de célula, e, modelo animal |
WO2013074986A1 (en) | 2011-11-17 | 2013-05-23 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
CA2873743C (en) | 2012-05-14 | 2022-12-06 | Prostagene, Llc | Using modulators of ccr5 for treating cancer |
CA2876780A1 (en) | 2012-06-26 | 2014-01-03 | Saniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
CN105283206B (zh) * | 2013-03-27 | 2019-11-08 | 财团法人峨山社会福祉财团 | 包含p34的表达抑制剂或活性抑制剂作为有效成分的用于治疗或转移抑制癌的组合物 |
AU2014337044A1 (en) | 2013-10-18 | 2016-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
CN108064274A (zh) | 2014-07-30 | 2018-05-22 | 耶达研究及发展有限公司 | 用于培养多能干细胞的培养基 |
CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
EP3273966B1 (de) * | 2015-03-27 | 2023-05-03 | Dana-Farber Cancer Institute, Inc. | Hemmer von cyclinabhängigen kinasen |
WO2017044858A2 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
CN114149432B (zh) * | 2016-09-30 | 2024-07-05 | 斯坦福国际研究院 | 用于癌症治疗的双重clk/cdk1抑制剂 |
WO2020152686A1 (en) | 2019-01-23 | 2020-07-30 | Yeda Research And Development Co. Ltd. | Culture media for pluripotent stem cells |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3529497A1 (de) * | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
AU626983B2 (en) * | 1989-01-31 | 1992-08-13 | Whitby Research, Inc. | N6-substituted 9-methyladenines |
DK0625158T3 (da) * | 1992-01-06 | 1999-10-11 | Wellcome Found | Terapeutiske nucleosider af 2',3'-dideoxy-3'-fluorpurinrækken |
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
FR2741881B1 (fr) | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
US6107300A (en) | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
US5866702A (en) | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
US5753635A (en) | 1996-08-16 | 1998-05-19 | Berlex Laboratories, Inc. | Purine derivatives and their use as anti-coagulants |
WO1998016528A1 (en) | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
EP1578722A4 (de) * | 2001-10-12 | 2006-09-06 | Irm Llc | Kinaseinhibitorgerüste und verfahren zu deren herstellung |
WO2004035132A2 (en) * | 2002-10-15 | 2004-04-29 | Irm Llc | Compositions and methods for inducing osteogenesis |
-
1996
- 1996-10-22 CN CN96198457.0A patent/CN1066147C/zh not_active Expired - Fee Related
- 1996-10-22 PT PT96934774T patent/PT874846E/pt unknown
- 1996-10-22 JP JP50604797A patent/JP4004066B2/ja not_active Expired - Fee Related
- 1996-10-22 CA CA002234609A patent/CA2234609C/en not_active Expired - Fee Related
- 1996-10-22 AU AU72968/96A patent/AU7296896A/en not_active Abandoned
- 1996-10-22 EP EP96934774A patent/EP0874846B1/de not_active Expired - Lifetime
- 1996-10-22 DE DE69627195T patent/DE69627195T2/de not_active Expired - Lifetime
- 1996-10-22 US US09/051,827 patent/US7091346B1/en not_active Expired - Fee Related
- 1996-10-22 AT AT96934774T patent/ATE236161T1/de not_active IP Right Cessation
- 1996-10-22 WO PCT/EP1996/004573 patent/WO1997016452A1/en active IP Right Grant
- 1996-10-22 ES ES96934774T patent/ES2196181T3/es not_active Expired - Lifetime
- 1996-10-22 BR BR9611157A patent/BR9611157A/pt not_active Application Discontinuation
- 1996-10-30 AR ARP960104961A patent/AR004134A1/es unknown
-
1999
- 1999-04-08 HK HK99101415A patent/HK1016580A1/xx not_active IP Right Cessation
-
2007
- 2007-06-05 JP JP2007148965A patent/JP2007231023A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE236161T1 (de) | 2003-04-15 |
HK1016580A1 (en) | 1999-11-05 |
JPH11514336A (ja) | 1999-12-07 |
BR9611157A (pt) | 1999-03-30 |
CN1202896A (zh) | 1998-12-23 |
CA2234609A1 (en) | 1997-05-09 |
JP4004066B2 (ja) | 2007-11-07 |
EP0874846B1 (de) | 2003-04-02 |
WO1997016452A1 (en) | 1997-05-09 |
AR004134A1 (es) | 1998-09-30 |
CA2234609C (en) | 2006-11-28 |
US7091346B1 (en) | 2006-08-15 |
ES2196181T3 (es) | 2003-12-16 |
PT874846E (pt) | 2003-08-29 |
EP0874846A1 (de) | 1998-11-04 |
CN1066147C (zh) | 2001-05-23 |
AU7296896A (en) | 1997-05-22 |
JP2007231023A (ja) | 2007-09-13 |
DE69627195T2 (de) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69627195T2 (de) | Purinderivate und verfahren zu ihrer herstellung | |
DE59602652D1 (de) | Zahnbürste und verfahren zu ihrer herstellung | |
DE59606535D1 (de) | Furnacerusse und Verfahren zu ihrer Herstellung | |
DE69616717D1 (de) | Berührungssensoren und verfahren zu ihrer herstellung | |
DE69530989D1 (de) | Neue pyrimidinderivate und verfahren zu ihrer herstellung | |
DE69624457D1 (de) | ArOMATIsIERTE PRODUKTE UND VERFAHREN ZU IHRER HERSTELLUNG | |
ATA902992A (de) | Antigeschwulstmittel und verfahren zu ihrer herstellung | |
DE69729128D1 (de) | Taxoid-derivate und verfahren zu ihrer herstellung | |
DE69211697D1 (de) | Antischmelzsicherungsstruktur und verfahren zu ihrer herstellung | |
DE69825960D1 (de) | In 2-position substituierte 7-haloindene und verfahren zu ihrer herstellung | |
DE69615668T2 (de) | O-carbamoyl-(d)-phenylalanilolverbindungen und verfahren zu ihrer herstellung. | |
DE69625176D1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung | |
DE69608359T2 (de) | Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung | |
DE69433296D1 (de) | Eisen-lactoferrin kombination und verfahren zu ihrer herstellung | |
DE69510774T2 (de) | Katschukzusammensetzung und verfahren zu ihrer herstellung | |
DE69622368T2 (de) | Schwefelverbindungen und verfahren zu ihrer herstellung | |
ATE231840T1 (de) | Pyrrolidinylhydroxamsäuren und verfahren zu ihrer herstellung | |
DE69801795T2 (de) | Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung | |
DE69614524D1 (de) | Etherverbindungen und verfahren zu ihrer herstellung | |
DE69523571T2 (de) | Pyridylimidazol-derivate und verfahren zu ihrer herstellung | |
DE69527445D1 (de) | Aminooligosaccharid-derivate und verfahren zu ihrer herstellung | |
DE69528586D1 (de) | Imidazolderivate und verfahren zu ihrer herstellung | |
DE69609986T2 (de) | Bitumenzusammensetzungen und verfahren zu ihrer herstellung | |
DE69603746T2 (de) | Bitumenzusammensetzungen und verfahren zu ihrer herstellung | |
DE69718308T2 (de) | 4-fluorsalicylsäurederivate und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |